Celsion Corporation (CLSN)
(Delayed Data from NSDQ)
$2.18 USD
0.00 (-0.03%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.18 (%) 5:22 PM ET
NA Value NA Growth NA Momentum NA VGM
View All Zacks #1 Ranked Stocks
Brokerage Reports
0 items in cart
Imunon, Inc. [CLSN]
Reports for Purchase
Showing records 1 - 20 ( 145 total )
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
OVATION 2 Enrollment Complete; Interim Efficacy Data Trending in Favor of GEN-1 Treatment Arm
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Price: 5.00
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
Mouse Challenge Data Provide Validation of PLACCINE Platform Potential and Confirms Protection Against SARS-CoV-2
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Price: 5.00
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
Price: 5.00
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
2Q22 Take: OVATION-2 Enrollment to Complete This Month; Data Updates for GEN-1 and PLACCINE Expected 2H22
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Price: 5.00
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
Our Thoughts on Executive Changes; Early PFS Data From OVATION 2 Look Promising
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Price: 5.00
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
Celsion Has Cash, but is GEN-1 a Viable Product? We Remain Neutral on the Stock.
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Price: 5.00
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
1Q22 Take: Updates Across the Pipeline Expected in 2022
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Price: 5.00
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
Don''t Leave These Novel DNA-Based Platforms Stranded; Initiate at Buy and $16 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Price: 75.00
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
The DSMB Recommends to Continue Dosing Patients: GEN-1 in Advanced Ovarian Cancer. We Remain Neutral on the Stock
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Price: 5.00
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
Reports Third -Quarter Results: Cash Down to $25M; Share count Up to 86M -We Remain Neutral on the Stock
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Price: 5.00
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
Price: 25.00
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
Reports First-Quarter Results with $54M in Cash - We Remain Neutral on the Stock
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Price: 10.00
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
Lowering from BUY to Hold: IDMC Say?s ThermoDox Study Should be Halted
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Price: 10.00
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
Lowering from BUY to Hold: IDMC Say?s ThermoDox Study Should be Halted
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Price: 10.00
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
BUY: Celsion 1Q20 Results, $17.5M in Cash on Hand
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Price: 25.00
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
Price: 25.00
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
Hitting on All Cylinders: Thermodox - OVATION
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Price: 25.00
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
The Verdict is Unanimous DSMB Says Full Speed Ahead
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Price: 25.00
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
Price: 25.00
Company: Imunon, Inc.
Industry: Medical - Biomedical and Genetics
The Future of Therapeutic Oncology, Optimized Treatment, and a Higher Quality of Life for Cancer Patients.
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Price: 50.00